Mesoblast (MESO) Long-Term Investments (2015 - 2025)
Mesoblast's (MESO) quarterly Long-Term Investments came in at $4.6 million in Q4 2025, down 14.36% year-on-year from $5.4 million in Q4 2024, and down 14.36% quarter-over-quarter from $5.4 million in Q4 2024.
Mesoblast (MESO) Long-Term Investments (2015 - 2025) Analysis & Trends
Mesoblast has disclosed Long-Term Investments across 7 years of filings, most recently posting $4.6 million for Q4 2025.
- Long-Term Investments for Q4 2025 came in at $4.6 million, down 14.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.6 million (down 14.36% YoY), and the FY2018 annual result was $2.3 million, up 16.22% from the prior year.
- Long-Term Investments came in at $4.6 million for Q4 2025 at Mesoblast, down from $5.4 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $5.4 million in Q4 2024 to a low of $2.2 million in Q4 2023.
- The 3-year median for Long-Term Investments is $4.6 million (2025), against an average of $4.1 million.
- Across the five-year window, Long-Term Investments surged 148.33% in 2024 and fell 14.36% in 2025, its largest moves.
- Mesoblast's Long-Term Investments stood at $2.2 million in 2023, then soared by 148.33% to $5.4 million in 2024, then slipped by 14.36% to $4.6 million in 2025.
- The last three Long-Term Investments figures came in at $4.6 million (Q4 2025), $5.4 million (Q4 2024), and $2.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 4.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.65 Mn |
| Dec 31, 2024 | 5.43 Mn |
| Dec 31, 2023 | 2.19 Mn |
| Sep 30, 2018 | 2.41 Mn |
| Jun 30, 2018 | 2.32 Mn |
| Mar 31, 2018 | 2.14 Mn |
| Dec 31, 2017 | 2.07 Mn |
| Sep 30, 2017 | 2.02 Mn |
| Jun 30, 2017 | 2.00 Mn |
| Mar 31, 2017 | 1.91 Mn |
| Dec 31, 2016 | 2.00 Mn |
| Jun 30, 2016 | 1.97 Mn |
| Dec 31, 2015 | 2.12 Mn |
| Jun 30, 2015 | 2.30 Mn |